WuXi AppTec moved to challenge its inclusion on a U.S. military-linked list, filing a lawsuit that disputes the government’s characterization and argues the designation has already caused “severe and irreparable harms.” The company said the listing triggers downstream impacts tied to the Biosecure Act and military procurement restrictions. In its filing, WuXi AppTec argued the designation subjects it to prohibitions that could prompt customers to shift business to non-covered suppliers. The dispute becomes strategically important as contract research organizations face increasing compliance and customer-management burdens under U.S. national security frameworks. The case highlights how regulatory and national security actions are increasingly treated as business-critical events for global biotech service providers, with direct implications for customer continuity and pipeline support.